BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 17655613)

  • 1. Uveitis masquerade syndromes: diffuse retinoblastoma in an older child.
    All-Ericsson C; Economou MA; Landau I; Träisk F; Seregard S
    Acta Ophthalmol Scand; 2007 Aug; 85(5):569-70. PubMed ID: 17655613
    [No Abstract]   [Full Text] [Related]  

  • 2. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
    Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
    Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the best treatment for retinoblastoma?
    Harbour JW
    Am J Ophthalmol; 2004 Sep; 138(3):471-3. PubMed ID: 15364232
    [No Abstract]   [Full Text] [Related]  

  • 4. Randomized, controlled trial in groups C and D retinoblastoma.
    Meel R; Bakhshi S; Pushker N; Vishnubhatla S
    Ophthalmology; 2015 Feb; 122(2):433-5. PubMed ID: 25439612
    [No Abstract]   [Full Text] [Related]  

  • 5. Trilateral retinoblastoma with pituitary-hypothalamic dysfunction.
    Dai S; Dimaras H; Héon E; Budning A; Doyle J; Halliday W; Drake J; Gallie BL; Chan HS
    Ophthalmic Genet; 2008 Sep; 29(3):120-5. PubMed ID: 18766991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoma underlying retinoblastoma revealed after tumor response to 1 cycle of chemotherapy.
    Dimaras H; Khetan V; Halliday W; Héon E; Chan HS; Gallie BL
    Arch Ophthalmol; 2009 Aug; 127(8):1066-8. PubMed ID: 19667353
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors.
    Shields CL; Mashayekhi A; Cater J; Shelil A; Meadows AT; Shields JA
    Am J Ophthalmol; 2004 Sep; 138(3):329-37. PubMed ID: 15364213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
    Schefler AC; Cicciarelli N; Feuer W; Toledano S; Murray TG
    Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical manifestations and treatment of retinoblastoma in Korea.
    Chung SE; Sa HS; Koo HH; Yoo KH; Sung KW; Ham DI
    Br J Ophthalmol; 2008 Sep; 92(9):1180-4. PubMed ID: 18650212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Risk Retinoblastoma: Prevalence and Success of Treatment in Developing Countries.
    ElZomor H; Taha H; Aleieldin A; Nour R; Zaghloul MS; Fawzi M; Kamel A; Alfaar AS
    Ophthalmic Genet; 2015; 36(3):287-9. PubMed ID: 25945688
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes.
    Shields CL; Ramasubramanian A; Thangappan A; Hartzell K; Leahey A; Meadows AT; Shields JA
    Ophthalmology; 2009 Mar; 116(3):544-551.e1. PubMed ID: 19157557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The International Classification of Retinoblastoma predicts chemoreduction success.
    Shields CL; Mashayekhi A; Au AK; Czyz C; Leahey A; Meadows AT; Shields JA
    Ophthalmology; 2006 Dec; 113(12):2276-80. PubMed ID: 16996605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orbital fibrosis and intraocular recurrence of retinoblastoma following periocular carboplatin.
    Kim JW; Yau JW; Moshfeghi D; Fishman M
    J Pediatr Ophthalmol Strabismus; 2010 May; 47 Online():e1-4. PubMed ID: 21214147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New strategies in the management of retinoblastoma].
    Balmer A; Munier F; Zografos L
    J Fr Ophtalmol; 2002 Feb; 25(2):187-93. PubMed ID: 11941242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of advanced retinoblastoma with intravenous chemotherapy then intra-arterial chemotherapy as alternative to enucleation.
    Shields CL; Kaliki S; Al-Dahmash S; Rojanaporn D; Leahey A; Griffin G; Jabbour P; Shields JA
    Retina; 2013; 33(10):2103-9. PubMed ID: 23873161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant uveitis masquerade syndromes.
    Kubicka-Trzaska A; Romanowska-Dixon B
    Klin Oczna; 2008; 110(4-6):199-202. PubMed ID: 18655462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel deep intronic low penetrance RB1 variant in a retinoblastoma family.
    Soliman SE; Racher H; Lambourne M; Matevski D; MacDonald H; Gallie B
    Ophthalmic Genet; 2018 Apr; 39(2):288-290. PubMed ID: 29099630
    [No Abstract]   [Full Text] [Related]  

  • 18. [Masking syndromes in oncology of the pediatric eye].
    Rehůrek J
    Cesk Slov Oftalmol; 1997 Oct; 53(5):293-7. PubMed ID: 9508494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Foveal microanatomy documented by SD-OCT following treatment of advanced retinoblastoma.
    Samara WA; Pointdujour-Lim R; Say EA; Shields CL
    J AAPOS; 2015 Aug; 19(4):368-72. PubMed ID: 26235789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resolution of iris neovascularization following chemoreduction of retinoblastoma.
    Patel J; Turaka K; Shields CL
    J Pediatr Ophthalmol Strabismus; 2010 Oct; 47 Online():e1-3. PubMed ID: 21162463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.